404 related articles for article (PubMed ID: 17100888)
21. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
22. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients.
Cai L; Zhang Z; Zhou L; Wang H; Fu J; Zhang S; Shi M; Zhang H; Yang Y; Wu H; Tien P; Wang FS
Clin Immunol; 2008 Dec; 129(3):428-37. PubMed ID: 18824414
[TBL] [Abstract][Full Text] [Related]
23. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
[TBL] [Abstract][Full Text] [Related]
24. IL-15 renders conventional lymphocytes resistant to suppressive functions of regulatory T cells through activation of the phosphatidylinositol 3-kinase pathway.
Ben Ahmed M; Belhadj Hmida N; Moes N; Buyse S; Abdeladhim M; Louzir H; Cerf-Bensussan N
J Immunol; 2009 Jun; 182(11):6763-70. PubMed ID: 19454671
[TBL] [Abstract][Full Text] [Related]
25. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of tumor escape: role of tumor microenvironment in inducing apoptosis of cytolytic effector cells.
Poggi A; Zocchi MR
Arch Immunol Ther Exp (Warsz); 2006; 54(5):323-33. PubMed ID: 17031467
[TBL] [Abstract][Full Text] [Related]
27. IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells.
Vahlne G; Becker S; Brodin P; Johansson MH
Scand J Immunol; 2008 Jan; 67(1):1-11. PubMed ID: 18028287
[TBL] [Abstract][Full Text] [Related]
28. The dual effects of interleukin-18 in tumor progression.
Park S; Cheon S; Cho D
Cell Mol Immunol; 2007 Oct; 4(5):329-35. PubMed ID: 17976312
[TBL] [Abstract][Full Text] [Related]
29. Trogocytosis-based generation of suppressive NK cells.
Caumartin J; Favier B; Daouya M; Guillard C; Moreau P; Carosella ED; LeMaoult J
EMBO J; 2007 Mar; 26(5):1423-33. PubMed ID: 17318190
[TBL] [Abstract][Full Text] [Related]
30. CD25+ regulatory T cell inhibition enhances vaccine-induced immunity to neuroblastoma.
Johnson BD; Jing W; Orentas RJ
J Immunother; 2007; 30(2):203-14. PubMed ID: 17471167
[TBL] [Abstract][Full Text] [Related]
31. Cross-talk between NKT and regulatory T cells (Tregs) in modulation of immune response in patients with colorectal cancer following different pain management techniques.
Mrakovcić-Sutić I; Bacić D; Golubović S; Bacić R; Marinović M
Coll Antropol; 2011 Sep; 35 Suppl 2():57-60. PubMed ID: 22220404
[TBL] [Abstract][Full Text] [Related]
32. Synergistic effects of IL-2, IL-12 and IL-18 on cytolytic activity, perforin expression and IFN-gamma production of porcine natural killer cells.
Pintaric M; Gerner W; Saalmüller A
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):68-82. PubMed ID: 17913242
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation.
Zhang C; Zhang J; Niu J; Zhang J; Tian Z
Cytokine; 2008 Apr; 42(1):128-36. PubMed ID: 18280748
[TBL] [Abstract][Full Text] [Related]
34. Regulatory T cells and asthma.
Robinson DS
Clin Exp Allergy; 2009 Sep; 39(9):1314-23. PubMed ID: 19538496
[TBL] [Abstract][Full Text] [Related]
35. The regulatory effect of natural killer cells: do "NK-reg cells" exist?
Zhang C; Zhang J; Tian Z
Cell Mol Immunol; 2006 Aug; 3(4):241-54. PubMed ID: 16978532
[TBL] [Abstract][Full Text] [Related]
36. [Influence of high mobility group box-1 protein on the correlation between regulatory T cells and CD4+ CD25- T cells of spleen in mice].
Zhang Y; Yao YM; Yu Y; Wu Y; Sheng ZY
Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(3):217-20. PubMed ID: 18683721
[TBL] [Abstract][Full Text] [Related]
37. Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients.
Wada J; Yamasaki A; Nagai S; Yanai K; Fuchino K; Kameda C; Tanaka H; Koga K; Nakashima H; Nakamura M; Tanaka M; Katano M; Morisaki T
Anticancer Res; 2008; 28(4C):2401-8. PubMed ID: 18751426
[TBL] [Abstract][Full Text] [Related]
38. Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms.
Lizée G; Radvanyi LG; Overwijk WW; Hwu P
Clin Cancer Res; 2006 Aug; 12(16):4794-803. PubMed ID: 16914564
[TBL] [Abstract][Full Text] [Related]
39. CD4+CD25+ Tregs and NKT cells: regulators regulating regulators.
La Cava A; Van Kaer L; Fu-Dong-Shi
Trends Immunol; 2006 Jul; 27(7):322-7. PubMed ID: 16735139
[TBL] [Abstract][Full Text] [Related]
40. Peripheral Foxp3+ regulatory T cells and natural killer group 2, member D expression levels in natural killer cells of patients with colorectal cancer.
Shen Y; Wang Q; Qi Y; Cui B; Zhang Z; Su J; Liu X; Lu C; Ye H; Ju Y; Lu Z
Mol Med Rep; 2014 Aug; 10(2):977-82. PubMed ID: 24819058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
